Skip to content
10-Q

Quarterly Report

GlobeStar Therapeutics Corp

0001161697-23-000456

← back to feed
Filed
Aug 17, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Aug 14, 2023 934.89M sh
Stock Issued Q3 2023 · Jun 30, 2023 7.26M sh
Current Liabilities Q3 2023 · Jun 30, 2023 $1.28M
Current Liabilities Q3 2023 · Sep 30, 2022 $1.2M
Total Liabilities Q3 2023 · Jun 30, 2023 $1.28M
Total Liabilities Q3 2023 · Sep 30, 2022 $1.2M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $6.37K
Current Assets Q3 2023 · Sep 30, 2022 $9.92K
Total Assets Q3 2023 · Sep 30, 2022 $9.92K